Azopharma Adds Two Units

Azopharma has added a pair of companies to its Azopharma Product Development Group: ApiCross Drug Delivery Technologies and AvivoClin Clinical Services. Based in Hollywood, FL, ApiCross’s technology platforms focus on bioavailability enhancement, customized drug release, taste masking and cytotoxic and highly potent compounds. AvivoClin, which will launch in early 2008, is a clinical pharmacology unit designed to accommodate short- and long-term studies. The unit will offer customized solutions for early Phase I and IIa clinical research studies.

The two units will join Cyanta Analytical Laboratories, IQsynthesis and AniClin Preclinical Services, along with Azopharma Contract Pharmaceutical Services. Said Azopharma chief executive officer Phil Meeks, “With these two additions to our service line, Azopharma can now provide the full spectrum of solutions for product development in the pharmaceutical, biotechnology and medical device industries from discovery through Phase I/IIa clinical studies.”